ALIMERA SCIENCES INC·4

Dec 16, 4:47 PM ET

Kaba Samer 4

4 · ALIMERA SCIENCES INC · Filed Dec 16, 2019

Insider Transaction Report

Form 4
Period: 2019-12-13
Kaba Samer
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2019-12-13$8.24/sh+86$7095,579 total
Footnotes (1)
  • [F1]These shares were acquired pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 4, 2019.

Documents

1 file
  • 4
    wf-form4_157653284151468.xmlPrimary

    FORM 4